microdosing oral semaglutide Benefits of GLP-1 GLP-1 (glucagon-like peptide-1) receptor agonists, such as tirzepatide (Zepbound) or (Ozempic, Wegovy), are typically prescribed for diabetes and obesity management at standard therapeutic doses. Microdosing Microdosing GLP-1s: Safety, Dosage, Side

The FDA strongly recommends using only approved versions of GLP-1 medications under proper medical supervision

Both drugs are approved by the Food and Drug AdministrationWegovy for weight management and Ozempic for diabetes

It's worth noting that GLP-1 receptor agonists typically have a low risk of causing hypoglycaemia in adults when used alone, but any transfer to the infant could potentially influence blood sugar regulation in vulnerable newborns

But GLP-1 receptors are not just in the gut and brain

Body composition changes are visible by week two to four in users who are disciplined with diet and training

GLP-1 receptor agonists can trigger nausea by acting on CNS pathways, which is why some providers believe B6 may help mitigate these effects